Business Description
INIFY Laboratories AB
ISIN : SE0017486103
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 16.24 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 38.67 | |||||
9-Day RSI | 42.2 | |||||
14-Day RSI | 44.59 | |||||
6-1 Month Momentum % | -25.17 | |||||
12-1 Month Momentum % | -42.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 5.35 | |||||
Quick Ratio | 5.27 | |||||
Cash Ratio | 4.53 | |||||
Days Inventory | 134.49 | |||||
Days Sales Outstanding | 240.58 | |||||
Days Payable | 932.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History |
---|
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 82.97 | |||||
Operating Margin % | -772.89 | |||||
Net Margin % | -730.92 | |||||
ROE % | -59.62 | |||||
ROA % | -54.29 | |||||
ROIC % | -219.92 | |||||
ROC (Joel Greenblatt) % | -530.12 | |||||
ROCE % | -59.55 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 43.55 | |||||
PB Ratio | 5.06 | |||||
Price-to-Tangible-Book | 5.4 | |||||
EV-to-EBIT | -4.81 | |||||
EV-to-EBITDA | -5.28 | |||||
EV-to-Revenue | 35.11 | |||||
Price-to-Net-Current-Asset-Value | 6.94 | |||||
Price-to-Net-Cash | 8.1 | |||||
Earnings Yield (Greenblatt) % | -20.79 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
INIFY Laboratories AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 0.61 | ||
EPS (TTM) (€) | -0.099 | ||
Beta | 0 | ||
Volatility % | 49.02 | ||
14-Day RSI | 44.59 | ||
14-Day ATR (€) | 0.048856 | ||
20-Day SMA (€) | 0.52785 | ||
12-1 Month Momentum % | -42.95 | ||
52-Week Range (€) | 0.432 - 1.13 | ||
Shares Outstanding (Mil) | 45.24 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
INIFY Laboratories AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
INIFY Laboratories AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
INIFY Laboratories AB Frequently Asked Questions
What is INIFY Laboratories AB(STU:WY60)'s stock price today?
When is next earnings date of INIFY Laboratories AB(STU:WY60)?
Does INIFY Laboratories AB(STU:WY60) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |